EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study

Lucas Yixi Xing iD, Søren Højberg iD, Derk W Kriegerg, Claus Graff, Morten S Olesen iD, Jeff S Healey iD, William F McIntyre iD, Axel Brandes iD, Lars Køber iD, Ketil Jørgen Haugan iD, Jesper Hastrup Svendsen iD, Søren Zöga Diederichsen iD

Circulation: Arrhythmia and Electrophysiology · 2024

DOI: 10.1161/circep.124.012764 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2024. Verfasst von Lucas Yixi Xing und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Denmark (L.Y.X., M.S.O., L.K., J.H.S., S.Z.D.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mounting evidence indicates that even device-detected subclinical atrial fibrillation is associated with a higher risk of heart failure (HF). However, the potential impact of atrial fibrillation screening on HF remains unknown. METHODS: The LOOP Study (Atrial Fibrillation detected by Continuous ECG Monitoring using Implantable Loop Recorder to prevent Stroke in High-risk Individuals) evaluated the effects of atrial fibrillation screening on stroke prevention using an implantable loop recorder (ILR) versus usual care in older individuals with additional stroke risk factors. In this secondary analysis, we explored the following HF end points: (1) HF event or cardiovascular death; (2) HF event; (3) event with HF with reduced ejection fraction (HFrEF); and (4) HFrEF event or cardiovascular death. Outcomes were assessed in a Cox model both as time-to-first events and as total (first and recurrent) events analyzed using the Andersen-and-Gill method. RESULTS: Of 6004 participants (mean age 74.7 and 52.7% men), 1501 were randomized to ILR screening and 4503 to the control group. In total, 77 (5.1%) in the ILR group versus 295 (6.6%) in the control group experienced the primary outcome of an HF event or cardiovascular death. Compared with usual care, ILR screening was associated with a nonsignificant reduction in the primary outcome for the time-to-first event analysis (hazard ratio, 0.78 [95% CI, 0.61–1.01]) and the total event analysis (hazard ratio, 0.77 [95% CI, 0.59–1.01]). Similar results were obtained for the HF event. A significant risk reduction in total events was observed in the ILR group for the composite of HFrEF event or cardiovascular death and for HFrEF event (hazard ratio, 0.74 [95% CI, 0.56–0.98] and 0.65 [95% CI, 0.44–0.97], respectively). CONCLUSIONS: In an older population with additional stroke risk factors, ILR screening for atrial fibrillation tended to be associated with a lower rate of total HF events and cardiovascular death, particularly those related to HFrEF. These findings should be considered hypothesis-generating and warrant further investigation. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02036450.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureAgedFemaleHumansMaleElectrocardiography, AmbulatoryHeart RateMass ScreeningPredictive Value of TestsRisk AssessmentRisk FactorsStrokeStroke VolumeTime Factors

Stichwörter der Autor:innen

atrial fibrillationcontrol groupheart failurerisk factorsstroke

Autor:innen und Institutionen

  • Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Denmark (L.Y.X., M.S.O., L.K., J.H.S., S.Z.D.).
  • Department of Cardiology, Zealand University Hospital, Roskilde, Denmark (L.Y.X., K.J.H.).
  • Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada (L.Y.X., J.S.H., W.F.M.I.).
  • Department of Cardiology, Copenhagen University Hospital, Denmark (S.H., S.Z.D.).
  • Department of Neurology, Mediclinic City Hospital, Dubai, United Arabic Emirates (D.W.K.).
  • Department of Neuroscience, Mohammed Bin Rashid University of Medicine and Health Science, Dubai, United Arabic Emirates (D.W.K.).

ORCID-Profile: Lucas Yixi Xing, Søren Højberg, Morten S Olesen, Jeff S Healey, William F McIntyre, Axel Brandes, Lars Køber, Ketil Jørgen Haugan, Jesper Hastrup Svendsen, Søren Zöga Diederichsen

Zitieren

APA

Xing, L. Y., Højberg, S., Kriegerg, D. W., Graff, C., Olesen, M. S., Healey, J. S., McIntyre, W. F., Brandes, A., Køber, L., Haugan, K. J., Svendsen, J. H., & Diederichsen, S. Z. (2024). Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.124.012764

Vancouver

Xing LY, Højberg S, Kriegerg DW, Graff C, Olesen MS, Healey JS, et al. Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study. Circulation: Arrhythmia and Electrophysiology. 2024. doi:10.1161/circep.124.012764

BibTeX
@article{Xing2024,
  author = {Xing, Lucas Yixi and Højberg, Søren and Kriegerg, Derk W and Graff, Claus and Olesen, Morten S and Healey, Jeff S and McIntyre, William F and Brandes, Axel and Køber, Lars and Haugan, Ketil Jørgen and Svendsen, Jesper Hastrup and Diederichsen, Søren Zöga},
  title = {Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study},
  journal = {Circulation: Arrhythmia and Electrophysiology},
  year = {2024},
  doi = {10.1161/circep.124.012764}
}
Kostenlos starten →